Tackling Counterfeit Drugs: The Challenges and Possibilities. [PDF]
Pharmaceut Med, 2023 Pathak R +3 more
europepmc +1 more source
Falsified and substandard medicines trafficking: A wakeup call for the African continent. [PDF]
Public Health Pract (Oxf), 2022 Wada YH +5 more
europepmc +1 more source
Analysis of pharmacovigilance databases for spontaneous reports of adverse drug reactions related to substandard and falsified medical products: A descriptive study. [PDF]
Front Pharmacol, 2022 Pozsgai K +6 more
europepmc +1 more source
Improved knowledge on substandard and falsified (SF) medical products through a dedicated course for pharmacy students at three universities in sub-Saharan Africa. [PDF]
BMJ Glob Health, 2023 Kusynová Z +8 more
europepmc +1 more source
Trends in counterfeit drugs and pharmaceuticals before and during COVID-19 pandemic. [PDF]
Forensic Sci Int, 2022 Ziavrou KS, Noguera S, Boumba VA.
europepmc +1 more source
THE EUROPEAN UNION FALSIFIED MEDICINES DIRECTIVE – IMPLEMENTED SAFETY FEATURES
International Journal of Biology, Pharmacy and Allied Sciences, 2021 openaire +1 more source
Tackling the global impact of substandard and falsified and unregistered/unlicensed anti-tuberculosis medicines. [PDF]
J Med Access, 2022 Akpobolokemi T +2 more
europepmc +1 more source
Why the EU's new Anti-Corruption Directive matters for health. [PDF]
Lancet Reg Health EurMcKee M, Balabanova D.
europepmc +1 more source
Substandard and falsified medicine recalls in the legitimate supply chain: a systematic review of evidence. [PDF]
BMJ OpenFryze I, Naughton BD.
europepmc +1 more source
Falsified Drugs in the Opinion of Patients Diagnosed with Cardiovascular Diseases-Nationwide and Cross-Sectional Study on the Example of EU-Member Country. [PDF]
Int J Environ Res Public Health, 2021 Świeczkowski D +3 more
europepmc +1 more source